Alfalfa (Medicago sativa, lucerne)
Alfalfa (Medicago sativa, also called lucerne) is a leguminous forage plant used as a Western herbalism remedy, an animal feed crop, and a fresh sprout in salads. It is sold in the UK as a food supplement (leaf, seed, sprout) at modest doses. There are NO UK-authorised health claims for alfalfa — claims for cholesterol reduction, menopause symptoms, "blood purification", and detoxification are all unauthorised. Two specific safety issues shape the responsible position: alfalfa contains L-canavanine, a non-protein amino acid that has triggered systemic-lupus-like reactions in animal studies and case reports in humans (Malinow 1982, Alcocer-Varela 1985); alfalfa sprouts are also one of the most common vehicles for Salmonella and E. coli foodborne illness. Camden does not stock or recommend alfalfa supplements.
Camden Medicals editorial · Last reviewed 6 May 2026 · Next review May 2027
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Botanical
- Typical daily dose
- No defined therapeutic range. UK food supplement labels typically 200-1000 mg dried-leaf per day. Sprout consumption (food-tier) is dose-undefined and varies by salad portion size.
- Top use evidence
- Strong
On this page
What it is
Alfalfa (Medicago sativa) is a perennial flowering legume in the Fabaceae family, native to South-Central Asia, cultivated worldwide as a hay/forage crop ("lucerne" in UK farming use). The plant fixes atmospheric nitrogen via root-nodule symbiosis with Sinorhizobium bacteria — one of the reasons it has been a staple of soil-rotation farming for centuries.
The parts used in Western herbalism are the leaf and aerial parts (cut at flowering), the seed, and the sprout. Constituents of interest include:
- Phytoestrogens (coumestrol — a coumestan that binds estrogen receptors).
- Saponins (alfalfa saponins, with foaming behaviour and reported cholesterol-binding in animal studies).
- L-canavanine (a non-protein amino acid analogue of L-arginine, concentrated in seeds and sprouts).
- Vitamin K1 (phylloquinone — green leaf contains substantial amounts).
- Multiple trace vitamins and minerals.
Alfalfa is sold in the UK as a food supplement (leaf powder, seed, capsule) and as a fresh sprout for salad. The sprout form is the most-implicated in foodborne-illness outbreaks because the warm, humid sprouting conditions are conducive to Salmonella and E. coli growth from contaminated seed. The supplement form is generally low-dose dried leaf (200-1000 mg/day) — at this scale L-canavanine exposure is small but the autoimmune concern means autoimmune-disease patients should avoid it entirely.
Alfalfa has NO UK-authorised health claims. Traditional Herbal Registration (THR) under the Traditional Herbal Medicines Directive is the only legal pathway for medicinal claims, and alfalfa does not currently hold a THR certificate.
At a glance
- No UK-authorised health claim. Marketing must stay descriptive (traditional use). Cholesterol, menopause, "blood-purifier", and detox claims are not permitted.
- L-canavanine — a non-protein amino acid in alfalfa seeds and sprouts — induced an SLE-like syndrome in cynomolgus macaques in a foundational 1982 Science paper (Malinow); subsequent in vitro work (Alcocer-Varela 1985) showed L-canavanine alters human T-cell regulation. Case reports in lupus patients have linked alfalfa exposure to disease flare. People with lupus or other autoimmune conditions should AVOID alfalfa supplements.
- Vitamin K content interacts with warfarin and other vitamin-K-antagonist anticoagulants — alfalfa green leaf is dense in vitamin K1 and can destabilise INR. Tell your anticoagulation clinic about all alfalfa/sprout intake.
- Alfalfa sprouts are one of the most common foodborne-illness vehicles in the UK and US — Salmonella, E. coli O157:H7. Pregnant women and immunocompromised adults should avoid raw alfalfa sprouts entirely.
- Pregnancy: avoid concentrated alfalfa supplements — the plant has phytoestrogen (coumestrol) content and traditional uterotonic use; safety in pregnancy is not established.
What people use it for
Adults with no underlying autoimmune or anticoagulant context, considering alfalfa for "general wellness"
There is no UK-authorised health claim for alfalfa for any indication. Marketing must therefore be strictly descriptive (traditional Western herbalism use; nutritional contribution from leaf consumption). Camden does not stock alfalfa supplements because the favourable benefit-evidence is thin and the safety considerations meaningful.
Popular, not provenInsufficientPeople with systemic lupus erythematosus, rheumatoid arthritis, or other autoimmune conditions
AVOID alfalfa supplements and minimise alfalfa-sprout intake. The L-canavanine content is the specific concern; case reports and animal studies link alfalfa exposure to SLE flare. [4,5]
Some evidenceLimitedPeople taking warfarin or other vitamin-K-antagonist anticoagulants
AVOID alfalfa supplements and consume alfalfa-leaf foods only in stable, declared amounts. The vitamin K1 content reverses warfarin's effect and destabilises INR. Tell your anticoagulation clinic about all dietary changes including alfalfa or sprout intake. [2]
Some evidenceStrongPregnant women, breastfeeding women, immunocompromised adults
AVOID raw alfalfa sprouts — they are one of the most common UK and US foodborne-illness vehicles (Salmonella, E. coli). Avoid concentrated alfalfa supplements in pregnancy because of phytoestrogen content (coumestrol) and traditional uterotonic associations; pregnancy safety is not established. [1]
Some evidenceStrong
How it works
Alfalfa's reported biological effects come from a mix of phytoestrogens (coumestrol binding estrogen receptors), saponins (binding cholesterol micelles in the gut), L-canavanine (incorporated into proteins in place of arginine, plausibly disrupting T-cell regulation as shown in vitro), and vitamin K (reversing warfarin effect). None of these mechanisms is the basis for a UK-authorised health claim.
Common myths
Myth""Alfalfa lowers cholesterol.""
RealityNo UK-authorised cholesterol claim. Some animal-model evidence supports a mechanism (alfalfa saponins binding bile acids) but the human RCT evidence is too thin to support clinical use, and UK marketing cannot make cholesterol claims for alfalfa.
Myth""Alfalfa is a safe everyday herbal.""
RealityNot for everyone. People with systemic lupus erythematosus, related autoimmune conditions, or warfarin-anticoagulation should avoid alfalfa. Pregnant women should avoid concentrated supplements. Immunocompromised people should avoid raw sprouts. The "safe everyday herbal" framing misrepresents the actual safety profile. [4]
Myth""Alfalfa sprouts are a healthy raw food.""
RealityAlfalfa sprouts are nutritionally fine for healthy adults but are one of the most common food vehicles for Salmonella and E. coli outbreaks in the UK and US — the warm, humid sprouting conditions favour bacterial growth from contaminated seed. UK and US food-safety guidance specifically warns pregnant women and immunocompromised adults against raw sprouts. [1]
Myth""Alfalfa cleans the blood / detoxifies.""
RealityNon-regulated marketing language with no defined clinical endpoint. The body has functioning hepatic, renal, and lymphatic systems for handling endogenous and exogenous compounds; "blood purification" is not a recognised health-claim framework in UK or EU regulation.
Common online questions
Synthesised from the questions UK shoppers most often ask online about Alfalfa (Medicago sativa, lucerne). Each answer is editorial and links to its evidence in the Sources list below.
I have lupus — can I take alfalfa?
No. People with systemic lupus erythematosus or related autoimmune conditions should avoid alfalfa supplements and minimise alfalfa-sprout intake. The L-canavanine in alfalfa has been implicated in SLE flare in animal studies (Malinow 1982) and in vitro T-cell work (Alcocer-Varela 1985). Lupus is a serious condition and the conservative position is firm avoidance. [4,5]
I take warfarin — is alfalfa OK?
No, not without your anticoagulation clinic's input. Alfalfa green leaf contains substantial vitamin K1, which reverses warfarin's effect and can destabilise INR. The same applies to alfalfa-leaf-based "green superfood" blends. Tell your clinic about all dietary changes including alfalfa or sprout intake. [2]
I''m pregnant — can I eat alfalfa sprouts?
No. UK Department of Health pregnancy guidance specifically warns against raw alfalfa, mung bean, and other sprouts because of foodborne-illness risk (Salmonella, E. coli). Cooked alfalfa-leaf vegetable would be acceptable but is uncommon in UK cuisine. Avoid concentrated alfalfa supplements in pregnancy because of phytoestrogen content and traditional uterotonic associations. [1]
Does alfalfa "purify the blood"?
This is non-regulated marketing language with no defined clinical meaning. The liver, kidneys, and lymphatic system are the body's working purification systems. "Blood purifier" is not a recognised UK or EU health-claim framework. Marketing alfalfa or any other supplement with this wording is not permitted.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
SLE flare / autoimmune-disease activation
LimitedEvidencelimitedFoundational evidence is animal-model: Malinow 1982 (Science) showed cynomolgus macaques fed alfalfa sprouts developed SLE-like haematologic and serologic abnormalities, reactivated by feeding pure L-canavanine sulphate. In vitro work by Alcocer-Varela 1985 (Arthritis & Rheumatism) showed L-canavanine has dose-dependent effects on human T-cell regulation — diminishing mitogenic responses and abrogating concanavalin-A-induced suppressor-cell function — providing a plausible mechanism for SLE induction or exacerbation. Human case reports have linked alfalfa exposure to SLE flare; large-scale prospective evidence is absent. The conservative interpretation: lupus patients and their first-degree relatives should avoid alfalfa supplements. [4,5]
Cholesterol reduction
InsufficientEvidenceinsufficientAnimal-model and small uncontrolled human studies have suggested alfalfa saponins reduce cholesterol absorption from the gut. There is no UK-authorised cholesterol claim for alfalfa, and the human RCT footprint is too thin and too short to support clinical use.
Menopausal symptom relief
InsufficientEvidenceinsufficientAlfalfa contains coumestrol, a phytoestrogen, which has a theoretical rationale for menopausal symptom relief. There are no robust RCTs and no UK-authorised menopause claim for alfalfa. Other phytoestrogen sources (soy isoflavones) have substantially better trial data.
"Detoxification" / "blood purification"
InsufficientEvidenceinsufficientThese are non-regulated marketing terms with no defined biomarker or clinical endpoint. Not authorised under any UK health-claim framework.
Safety
Alfalfa is sold widely in UK herbal-supplement shops at low doses but carries three under-discussed safety concerns — autoimmune-disease flare risk via L-canavanine (lupus particularly), warfarin interaction via vitamin K1 content, and foodborne-illness risk from raw sprouts. Camden does not stock alfalfa.
Talk to your pharmacist or GP first if you:
- You have systemic lupus erythematosus, rheumatoid arthritis, Sjögren''s syndrome, or another autoimmune condition — avoid alfalfa supplements; the L-canavanine connection to SLE flare is documented.
- You take warfarin or other vitamin-K-antagonist anticoagulants — alfalfa-leaf supplements destabilise INR.
- You are pregnant, breastfeeding, or planning pregnancy — avoid raw sprouts; avoid concentrated alfalfa supplements.
- You are immunocompromised (chemotherapy, biologic DMARDs, post-transplant, advanced HIV) — avoid raw alfalfa sprouts.
- You take immunosuppressant medication (ciclosporin, tacrolimus, mycophenolate) — theoretical pharmacodynamic interaction; discuss with prescribing team.
- You take diabetes medication — alfalfa saponins have weak hypoglycaemic signals in animal models; monitor glucose if starting and tell your diabetes team.
Common side effects: Generally well-tolerated at typical UK supplement doses for healthy adults. Higher-risk groups (autoimmune disease, anticoagulation, pregnancy, immunocompromise) face the issues outlined above.
Pregnancy and breastfeeding
Avoid concentrated alfalfa supplements in pregnancy — phytoestrogen content (coumestrol), traditional uterotonic use, and absence of pregnancy-specific safety data. Avoid raw alfalfa sprouts entirely (UK Department of Health foodborne-illness guidance).
As pregnancy — avoid concentrated supplements; food-tier consumption of cooked alfalfa-leaf vegetable is acceptable but uncommon in UK cuisine.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Systemic lupus erythematosus and related autoimmune connective-tissue diseases.
- Concurrent warfarin or other vitamin-K-antagonist anticoagulation (relative — high-dose alfalfa).
- Pregnancy and women planning pregnancy (concentrated supplements).
- Documented legume hypersensitivity.
Drug interactions
- Warfarin / vitamin-K-antagonist anticoagulants (acenocoumarol, phenindione) — vitamin K1 content reverses anticoagulant effect; INR destabilisation. Tell anticoagulation clinic about all alfalfa intake.
- Immunosuppressants (ciclosporin, tacrolimus, mycophenolate, biologic DMARDs) — theoretical pharmacodynamic conflict; discuss with prescriber.
- Insulin / sulphonylureas / other antidiabetic agents — possible mild additive hypoglycaemia from alfalfa saponins; monitor glucose.
- Tamoxifen and aromatase inhibitors — theoretical phytoestrogen interaction via coumestrol content; specialist input needed.
- Hormone therapy (HRT, contraceptive pill) — theoretical phytoestrogen interaction.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- well-tolerated.
- Mild GI symptoms (bloating, flatulence) reported with high-dose seed or sprout consumption.
Rare side effects
- Photosensitivity rash from chronic high-dose alfalfa intake (case reports).
- Pancytopenia from very high-dose chronic intake (rare case reports).
- SLE flare or activation in susceptible individuals.
- Allergic reactions including urticaria and respiratory symptoms in legume-allergic individuals.
How to take it
- Typical supplemental range
- No defined therapeutic range. UK food supplement labels typically 200-1000 mg dried-leaf per day. Sprout consumption (food-tier) is dose-undefined and varies by salad portion size.
- Timing
- No specific timing requirement.
How to spot quality
Look for
- Plant species named in full: "Medicago sativa" — distinguishes from related Medicago species used differently.
- Plant part declared: "leaf" (most common in UK supplements), "seed" (higher L-canavanine — the autoimmune concern), "sprout" (foodborne-illness risk concern).
- L-canavanine content declaration — most UK supplement labels do not declare it; products that do are more transparent about the autoimmune-disease consideration.
- GMP-certified manufacture; pesticide and heavy-metals screen (alfalfa is heavily cultivated and accumulates soil contaminants).
Red flags
- "Lowers cholesterol" / "manages cholesterol" wording — not authorised.
- "Blood purifier" / "cleansing" / "detoxification process" wording — not authorised; non-regulated marketing language.
- "Menopause support" / "hormone balance" wording without a phytoestrogen-specific cited claim — alfalfa has no menopause claim.
- Marketing to people with lupus, rheumatoid arthritis, or other autoimmune conditions — directly counter to the L-canavanine literature.
- Raw sprout products without a "do not consume raw if pregnant or immunocompromised" warning.
- Combinations with warfarin or anticoagulants without prescriber-supervision warning — vitamin K interaction.